НовостиBenzingaGuggenheim Maintains Buy on Jade Biosciences, Lowers Price Target to $41 Guggenheim Maintains Buy on Jade Biosciences, Lowers Price Target to $41 Benzinga 2026.11.16 14:07 (GMT+0) Открыть на Benzinga Другие новости